{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039292","form_type":"8-K","ticker":null,"cik":"0001642375","company_name":"Guardion Health Sciences, Inc.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.076279+00:00","generated_at":"2026-05-30T21:34:34.356045+00:00","sec_items":["3.01","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Guardion Health Sciences to delist from Nasdaq, dissolve, and liquidate with ~$3.25/share distribution","bullets":["Voluntary delisting from Nasdaq effective Oct 21; trading suspended Oct 14; Form 25 filed ~Oct 11.","Certificate of dissolution filed Oct 22; stock transfer books close; no further stock transfers except by will.","Anticipated liquidating dividend of ~$3.25 per share; no assurance on timing or final amount; reserves possible additional distribution.","Mark Goldstone appointed Interim President and CEO effective Oct 18; compensation $7,500/month; replaces Janet Hall.","Company intends to suspend SEC reporting obligations via no-action relief."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039292","json":"https://secwatch.observer/filing/0001493152-24-039292.json","markdown":"https://secwatch.observer/filing/0001493152-24-039292.md","text":"https://secwatch.observer/filing/0001493152-24-039292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/0001493152-24-039292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:34:34.356045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d833a3e60","claim":"Mark Goldstone was appointed as Interim President and Interim Chief Executive Officer at Guardion Health Sciences, Inc..","evidence_excerpt":"On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/0001493152-24-039292-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim President and Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}